Science Explorer Back to mapMap
Discussion
Institution · Oklahoma Foundation for Digestive Research

Most cited papers from Oklahoma Foundation for Digestive Research

Oklahoma Foundation for Digestive Research

What are the most cited papers from Oklahoma Foundation for Digestive Research?

The most cited paper from Oklahoma Foundation for Digestive Research is "Gastric Acid Control With Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, and Rabeprazole: A Five-Way Crossover Study" (Philip B. Miner, Philip O. Katz, Yusong Chen et al., 2003), with 435 citations. Next come "A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation" (291) and "Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial." (285).

Showing 50 of 61 papers. Every paper with more than 38 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Gastric Acid Control With Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, and Rabeprazole: A Five-Way Crossover Study Philip B. Miner, Philip O. Katz, Yusong Chen et al. · The American Journal of Gastroenterology Dec 2003 435
2 A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation James S. Novick, Philip B. Miner, Richard A. Krause et al. · Alimentary Pharmacology & Therapeutics Open access 17 Oct 2002 291
3 Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Richard I. Breuer, Konrad H. Soergel, Bret A. Lashner et al. · Gut Open access Apr 1997 285
4 Omeprazole John A. Oates, Alastair J.J. Wood, Paul N. Maton · New England Journal of Medicine 4 Apr 1991 257
5 Economic and personal impact of fecal and urinary incontinence Philip B. Miner · Gastroenterology Open access 30 Dec 2003 254
6 Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis Christoph Benedikt Westphalen et al. · Cell stem cell Open access Apr 2016 239
7 Failure of a motilin receptor agonist (ABT‐229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double‐blind placebo‐controlled trial Nicholas Joseph Talley, Marleen H. Verlinden, William J. Snape et al. · Alimentary Pharmacology & Therapeutics 27 Dec 2000 222
8 Clinical Pharmacology of Proton Pump Inhibitors MALCOLM G. ROBINSON, John Horn · Drugs 2003 208
9 Psyllium is superior to docusate sodium for treatment of chronic constipation Mcrorie, McRorie, Daggy et al. · Alimentary Pharmacology & Therapeutics Open access May 1998 203
10 Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. Gregg R. Strohmeier, Wayne I. Lencer, Thomas W. Patapoff et al. · Journal of Clinical Investigation Open access Jun 1997 178
11 Antacids Revisited Paul N. Maton, Michael Burton · Drugs 1999 161
12 Enzyme replacement therapy for pancreatic insufficiency: present and future Martine Armand, Aaron P. Fieker, Jessica R. Philpott · Clinical and Experimental Gastroenterology Open access May 2011 156
13 Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial Philip B. Miner, William C. Orr, Joseph Filippone et al. · The American Journal of Gastroenterology Jun 2002 153
14 Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies Gautam Goel et al. · ˜The œLancet. Gastroenterology & hepatology Open access 11 May 2017 146
15 A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation Philip B. Miner, William D. Koltun, Gregory J. Wiener et al. · The American Journal of Gastroenterology Open access 7 Feb 2017 142
16 An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule‐1, in the treatment of chronic, unremitting pouchitis Philip B. Miner, Mark K. Wedel, Barbara L. Bane et al. · Alimentary Pharmacology & Therapeutics 20 Jan 2004 138
17 Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Joel E. Richter, Peter J. Kahrilas, J Johanson et al. · PubMed Mar 2001 129
18 Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats Beverley Greenwood-Van Meerveld, Matthew S. Gibson, Wesley Gunter et al. · Brain Research Mar 2001 128
19 A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis Sander J. H. van Deventer, Mark K. Wedel, Brenda F. Baker et al. · Alimentary Pharmacology & Therapeutics Open access 28 Apr 2006 127
20 Evidence for visceral hypersensitivity in high-anxiety rats Wesley Gunter, Jack D. Shepard, Robert D. Foreman et al. · Physiology & Behavior May 2000 120
21 Esophageal Hypersensitivity May Be A Major Cause of Heartburn Sheila Rodriguez-Stanley, Malcolm Robinson, David L Earnest et al. · The American Journal of Gastroenterology Mar 1999 117
22 Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts Shih‐Kuang S. Hong, David E. Loren, Jason N. Rogart et al. · Gastrointestinal Endoscopy 7 Feb 2012 110
23 Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation Anthony J Lembo, John F. Johanson, Henry P. Parkman et al. · Digestive Diseases and Sciences Open access 18 Jul 2011 108
24 Characterization of murine bone marrow and spleen-derived stromal cells: analysis of leukocyte marker and growth factor mRNA transcript levels JM Gimble, Carolynn E. Pietrangeli, Anna Henley et al. · Blood Open access Jul 1989 108
25 Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial Philip B. Miner, Mark K. Wedel, S. Xia et al. · Alimentary Pharmacology & Therapeutics Open access 28 Apr 2006 104
26 A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis MALCOLM G. ROBINSON, Bruce Sahba, Dennis L. Avner et al. · Alimentary Pharmacology & Therapeutics Feb 1995 104
27 Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration Jerry D. Gardner, Arthur A. Ciociola, MALCOLM G. ROBINSON · Journal of Applied Physiology Feb 2002 102
28 Hepatic Hemorrhage without Rupture in Preeclampsia Kenneth J. Manas, Jack D. Welsh, R. A. Rankin et al. · New England Journal of Medicine 14 Feb 1985 101
29 Esophageal Reflux in Conditioned Runners, Cyclists, and Weightlifters K COLLINGS, F. PIERCE PRATT, Sheila Rodriguez-Stanley et al. · Medicine & Science in Sports & Exercise May 2003 91
30 Onset of symptom relief with rabeprazole: a community‐based, open‐label assessment of patients with erosive oesophagitis MALCOLM G. ROBINSON, Stephanie J. Fitzgerald, R. M. Hegedüs et al. · Alimentary Pharmacology & Therapeutics Open access Mar 2002 88
31 The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study Kerri L. Glassner, Ayah Oglat, Antonio Duran et al. · Journal of Digestive Diseases 23 Apr 2020 84
32 Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors – overview and clinical implications MALCOLM G. ROBINSON · Alimentary Pharmacology & Therapeutics Open access 19 Oct 2004 81
33 Esophageal Visceral Sensitivity to Bile Salts in Patients with Functional Heartburn and in Healthy Control Subjects Ali Sarfraz Siddiqui, Sheila Rodriguez-Stanley, Sattar Zubaidi et al. · Digestive Diseases and Sciences 2005 76
34 The effects of capsaicin on reflux, gastric emptying and dyspepsia Rodriguez‐Stanley, Rodriguez‐Stanley, Collings et al. · Alimentary Pharmacology & Therapeutics Open access 2000 76
35 The effect of raw onions on acid reflux and reflux symptoms. Melvin L. Allen, Mark H. Mellow, MALCOLM G. ROBINSON et al. · PubMed Apr 1990 76
36 Effect of Tegaserod on Esophageal Pain Threshold, Regurgitation, and Symptom Relief in Patients With Functional Heartburn and Mechanical Sensitivity S. Rodriguez‐Stanley, Sattar Zubaidi, Howard M. Proskin et al. · Clinical Gastroenterology and Hepatology Apr 2006 75
37 Heartburn Requiring Frequent Antacid Use May Indicate Significant Illness Malcolm Robinson, David L Earnest, Sheila Rodriguez-Stanley et al. · Archives of Internal Medicine 23 Nov 1998 74
38 Health-Related Quality of Life Outcomes of Omeprazole versus Ranitidine in Poorly Responsive Symptomatic Gastroesophageal Reflux Disease Dennis A. Revicki, Sonja V. Sorensen, Paul N. Maton et al. · Digestive Diseases 1998 64
39 Pathophysiological effects of long-term acid suppression in man R F McCloy, R. Arnold, K. D. Bardhan et al. · Digestive Diseases and Sciences Feb 1995 63
40 Hyaluronan Biosynthesis by Class I Streptococcal Hyaluronan Synthases Occurs at the Reducing End Valarie L. Tlapak‐Simmons, Christina A. Baron, Russell R. Gotschall et al. · Journal of Biological Chemistry Open access 25 Jan 2005 62
41 Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats Karl R. Tyler, Cecilia J. Hillard, Beverley Greenwood–Van Meerveld · European Journal of Pharmacology Dec 2000 60
42 Review article: current perspectives on hypergastrinaemia and enterochromaffin‐like‐cell hyperplasia Robinson · Alimentary Pharmacology & Therapeutics Oct 1999 59
43 Use of octreotide acetate for control of symptoms in patients with islet cell tumors Paul N. Maton · World Journal of Surgery Jul 1993 58
44 The Effect of Esophageal Acid Volume on Arousals from Sleep and Acid Clearance William C. Orr, MALCOLM G. ROBINSON, Lawrence F. Johnson · CHEST Journal Feb 1991 56
45 Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease David C. Metz, Vijaya S.K. Pratha, Patrick T. Martin et al. · The American Journal of Gastroenterology Mar 2000 55
46 Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro‐oesophageal reflux disease MALCOLM G. ROBINSON, Paul N. Maton, Sheila Rodriguez et al. · Alimentary Pharmacology & Therapeutics Oct 1997 55
47 Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment Philip B. Miner, Lisa D Allgood, Julie Myers Grender · Alimentary Pharmacology & Therapeutics 6 Dec 2006 55
48 Medical therapy of inflammatory bowel disease for the 21st century MALCOLM G. ROBINSON · The European Journal of Surgery 26 Jul 2002 53
49 Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease Peter J. Kahrilas, Philip B. Miner, John F. Johanson et al. · Digestive Diseases and Sciences 21 Oct 2005 50
50 Attenuation by spinal cord stimulation of a nociceptive reflex generated by colorectal distention in a rat model Beverley Greenwood–Van Meerveld, Anthony C. Johnson, Robert D. Foreman et al. · Autonomic Neuroscience 30 Jan 2003 50

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.